List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 627 studies with search of: "Sclerosis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
2 Recruiting Genetics of ALS: Identification of Genes With Roles in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS) and Amyotrophic Lateral Sclerosis (ALS) With Frontotemporal Dementia
Conditions: Amyotrophic Lateral Sclerosis;   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
3 Completed Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing Remitting;   Multiple Sclerosis, Secondary Progressive
Intervention: Drug: ABT-874/Human monoclonal antibody against IL-12
4 Active, not recruiting Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
5 Not yet recruiting Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Progressive Relapsing Multiple Sclerosis
Intervention: Biological: Autologous mesenchymal stem cell transplantation
6 Active, not recruiting Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
Conditions: Multiple Sclerosis, Chronic Progressive;   Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: RTL1000 (recombinant T cell receptor ligand);   Drug: RTL1000 Placebo
7 Completed Safety of RG2077 in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: RG2077 (CTLA4-IgG4m)
8 Recruiting Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Conditions: Relapsing Remitting Multiple Sclerosis;   Multiple Sclerosis, Chronic Progressive
Intervention: Drug: Ritalin
9 Completed Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Secondary Progressive
Intervention: Biological: Tovaxin Autologous T Cell Vaccine
10 Not yet recruiting Bayer/Cognitive Assessments With Multiple Sclerosis Subjects
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Secondary Progressive
Intervention:
11 Active, not recruiting A Multi-Center, Multi-Regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
Condition: Multiple Sclerosis
Intervention:
12 Recruiting Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
Conditions: Relapsing-Remitting Multiple Sclerosis,;   Mono-Symptomatic Multiple Sclerosis
Intervention:
13 Active, not recruiting GER-009-06-AVX Early Therapy in Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention:
14 Recruiting A Study of Patients With Relapsing Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: LY2127399;   Drug: Placebo
15 Recruiting Gene Expression Profiles in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Procedure: Blood Draw
16 Terminated Study to Compare Double-Dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046);   Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
17 Not yet recruiting Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ACTHAR;   Drug: ACTHAR;   Drug: ACTHAR;   Drug: ACTHAR
18 Completed Rebif New Formulation in Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon-beta-1a FBS-free/HSA-free
19 Active, not recruiting Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
20 Active, not recruiting The Effects of TYSABRI Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: TYSABRI (natalizumab)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services